[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-343702-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-343702-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","melanoma-specific-mutation-hotspots-in-distal-non-coding-promoter-interacting-regions-implicate-novel-candidate-driver-genes","Melanoma-specific mutation hotspots in distal, non-coding, promoter-interacting regions implicate novel candidate driver genes","","Targeted melanoma therapy depends on identifying comprehensive genetic drivers, including those in non-coding DNA. This study uses melanoma Hi-C chromatin contact maps to define genome-wide distal regulatory elements that physically interact with promoters, then combines this with whole-genome sequence and gene expression data to model how somatic mutations influence promoter activity. Eight recurrent, melanoma-specific mutation hotspots are identified, altering transcription factor motifs and impacting gene expression, suggesting additional non-coding drivers beyond the TERT promoter.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/melanoma-specific-mutation-hotspots-in-distal-non-coding-promoter-interacting-regions-implicate-novel-candidate-driver-genes/343702/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/melanoma-specific-mutation-hotspots-in-distal-non-coding-promoter-interacting-regions-implicate-novel-candidate-driver-genes/343702.png","ImageObject",300,407,{"name":42,"@type":43},"Skyler","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are non-coding genetic drivers important in melanoma?","Question",{"text":63,"@type":64},"Non-coding regions can contain regulatory sites where mutations drive melanoma development. The study highlights that most known drivers are in coding regions, while distal non-coding regulatory elements remain less explored.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were distal promoter-interacting regulatory elements identified?",{"text":68,"@type":64},"The study uses Hi-C chromatin contact data from melanoma cells to map long-range, promoter-interacting distal regulatory elements across the genome.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the analysis find about mutation hotspots?",{"text":72,"@type":64},"Eight recurrent, melanoma-specific hotspots were identified in distal regulatory elements. These hotspots alter transcription factor binding motifs and affect expression of genes previously implicated in cancer, including HSPB7, CLDN1, ADCY9, and FDXR.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},343702,1790658085,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":112,"preview_page_count":33,"preview_urls":145},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","[www.nature.com/bjc](www.nature.com/bjc British)[ British](www.nature.com/bjc British) Journal of Cancer  \nARTICLE OPEN   \nGenetics and Genomics  \nMelanoma-speciﬁc mutation hotspots in distal, non-coding, promoter-interacting regions implicate novel candidate driver genes  \nMichael Pudjihartono1,2, Nicholas Pudjihartono1, Justin M. O’Sullivan1,2,3,4,5 ✉ and William Schierding 1,2,6 ✉  \n© The Author(s) 2024  \n\n|  | BACKGROUND: To develop targeted treatments, it is crucial to identify the full spectrum of genetic drivers in melanoma, including those in non-coding regions. However, recent efforts to explore non-coding regions have primarily focused on gene-adjacent elements such as promoters and non-coding RNAs, leaving intergenic distal regulatory elements largely unexplored.\u003Cbr>METHODS: We used Hi-C chromatin contact data from melanoma cells to map distal, non-coding, promoter-interacting regulatory elements genome-wide in melanoma. Using this “promoter-interaction network”, alongside whole-genome sequence and gene expression data from the Pan Cancer Analysis of Whole Genomes, we developed multivariate linear regression models to identify distal somatic mutation hotspots that affect promoter activity.\u003Cbr>RESULTS: We identiﬁed eight recurrently mutated hotspots that are novel, melanoma-speciﬁc, located in promoter-interacting distal regulatory elements, alter transcription factor binding motifs, and affect the expression of genes (e.g., HSPB7, CLDN1, ADCY9 and FDXR) previously implicated as tumour suppressors/oncogenes in various cancers.\u003Cbr>CONCLUSIONS: Our study suggests additional non-coding drivers beyond the well-characterised TERT promoter in melanoma, offering new insights into the disruption of complex regulatory networks by non-coding mutations that may contribute to melanoma development Furthermore, our study provides a framework for integrating multiple levels of biological data to uncover |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| .\u003Cbr>cancer-speciﬁc non-coding drivers. |  |  |\n|  | British Journal of Cancer (2024) 131:1644–1655; [https://doi.org/10.1038/s41416-024-02870-w](https://doi.org/10.1038/s41416-024-02870-w) |  |\n|  |  |  |\n\nBACKGROUND  \nSkin cancers rank as the most prevalent cancers worldwide [1], with melanoma being the deadliest amongst them [2]. To develop targeted treatments, it is crucial to identify the entire spectrum of sites that, when mutated, are causative of melanoma development. However, a large fraction of mutations in cancer genomes are passengers, which do not confer a detectable selective advantage to cells and, therefore, do not undergo positive selection [3] . Conversely, regional recurrence of somatic mutations is indicative of the positive selection process that marks driver events, contributing to tumorigenesis [4] .  \nLarge-scale cancer sequencing projects such as The Cancer Genome Atlas (TCGA) [5] and the International Cancer Genome Consortium (ICGC) [6] have initially focused on the coding regions, which led to the identiﬁcation of hundreds of driver mutations in protein-coding genes [7] . In contrast, few non-coding drivers are currently known. Thus far, the most characterised non-coding driver is located in the promoter of the telomerase reverse  \ntranscriptase (TERT) gene, which upregulates TERT expression in melanoma and many other cancer types [8–10] . It is hypothesised that many other non-coding drivers exist outside the TERT promoter. And so, there has been a shift in interest to systematically analyse the non-coding regions, which represent 98% of the human genome where the vast majority of somatic mutations reside [11], to identify potential driver mutations [12] . However, most large-scale efforts have concentrated on gene-adjacent noncoding elements (e.g., promoters and non-coding RNAs [9, 13–17]) leaving intergenic distal regulatory elements largely unexp","cbCaibOEamVAXT6o","https://ap.wps.com/l/cbCaibOEamVAXT6o","pdf",4516509,12,"English","# Background\n## Distal regulatory elements and non-coding driver discovery\n# Methods\n## Hi-C mapping and integrative regression modeling\n# Results\n## Recurrent mutation hotspots and affected genes\n# Conclusions\n## Additional melanoma non-coding drivers framework","[{\"question\":\"Why are non-coding genetic drivers important in melanoma?\",\"answer\":\"Non-coding regions can contain regulatory sites where mutations drive melanoma development. The study highlights that most known drivers are in coding regions, while distal non-coding regulatory elements remain less explored.\"},{\"question\":\"How were distal promoter-interacting regulatory elements identified?\",\"answer\":\"The study uses Hi-C chromatin contact data from melanoma cells to map long-range, promoter-interacting distal regulatory elements across the genome.\"},{\"question\":\"What did the analysis find about mutation hotspots?\",\"answer\":\"Eight recurrent, melanoma-specific hotspots were identified in distal regulatory elements. These hotspots alter transcription factor binding motifs and affect expression of genes previously implicated in cancer, including HSPB7, CLDN1, ADCY9, and FDXR.\"}]","Melanoma-specific mutation hotspots in distal, non-coding, promoter-interacting regions implicate novel candidate driver genes | PDF",1790051851,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/39b19de990f45b796e4b713c0ce6df81.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/678c26c8f3e0d5bcb392f81c8e1da0c6.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07243b142ecdd52c1b59f3e2e6311b43.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fbb66da113267827ad161d89ee4bcb09.webp",980,1301]